[1]
«Improving the Drug Bioavailability Property of Myricetin through a Structural Monosubstitution Modification Approach: an In-Silico Pharmacokinetics Study», AJBR, vol. 22, fasc. 3, pp. 347–352, dic. 2019, Consultato: 25 aprile 2026. [Online]. Disponibile su: https://ojshostng.com/index.php/ajbr/article/view/1335